Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière’s Disease: Case Report and Review of the Literature

<table>ACS cVEMP at 500 Hz (100 dB nHL) before (A) and after intratympanic gentamicin treatment from week 1 (B) to week 2 (C), week 3 (D), and week 4 (E).</table>

Case Reports in Otolaryngology

fig2

Figure 2

Figure 2: Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière’s Disease: Case Report and Review of the Literature 

Figure 2 | Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière’s Disease: Case Report and Review of the Literature 